; and (B) formulation of recommendations for applying and altering technologies and systems as described in subparagraph (A). (3) Report by HHS to Congress Not later than 30 days after completion of the review required by paragraph (1), the Secretary of Health and Human Services shall submit a report to the Congress on the timeline and actions necessary to implement the recommendations formulated under paragraph (2)(B). 6. Authorizing sustainable funding for the influenza ecosystem (a) Influenza Planning and Response Program There is authorized to be appropriated $231,000,000 for fiscal year 2024 and each subsequent fiscal year for programs and activities of the Centers for Disease Control and Prevention relating to influenza planning and response. (b) Strategic National Stockpile There is authorized to be appropriated $965,000,000 for fiscal year 2024 and each subsequent fiscal year for the Strategic National Stockpile under section 319F–2 of the Public Health Service Act ( 42 U.S.C. 247d–6b ). (c) Hospital Preparedness Program There is authorized to be appropriated $305,000,000 for fiscal year 2024 and each subsequent fiscal year for Hospital Preparedness Program of the Assistant Secretary for Preparedness and Response. (d) Universal Flu Vaccine Research There is authorized to be appropriated $270,000,000 for fiscal year 2024 and each subsequent fiscal year for research of the National Institutes of Health to develop a universal flu vaccine. (e) Immunization Program There is authorized to be appropriated $682,000,000 for fiscal year 2024 and each subsequent fiscal year for the immunization program of the Centers for Disease Control and Prevention under section 317 of the Public Health Service Act ( 42 U.S.C. 247b ). (f) Public Health Emergency Preparedness Program There is authorized to be appropriated $735,000,000 for fiscal year 2024 and each subsequent fiscal year for the Public Health Emergency Preparedness Program of the Centers for Disease Control and Prevention. (g) Infectious Disease Rapid Response